Back
Tvardi Therapeutics, Inc. TVRD · Insights
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of... Price1.41
Market Cap19.06 M
Float7.97 M
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro